Related references
Note: Only part of the references are listed.Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
A. Jayk Bernal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
Jennifer Hammond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study
Carlos K H Wong et al.
LANCET (2022)
Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge
Ronen Arbel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Phenotypes and Subphenotypes of Patients With COVID-19 A Latent Class Modeling Analysis
Xiaofeng Wang et al.
CHEST (2021)
Material community deprivation and hospital utilization during the first year of life: an urban population-based cohort study
Cole Brokamp et al.
ANNALS OF EPIDEMIOLOGY (2019)